126 results on '"Buglioni, Alessia"'
Search Results
2. Abstract 4143006: Systemic Vascular Damage and Cardiac Dysfunction in a Mouse Severe Acute Pancreatitis Model
3. Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis
4. Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion
5. Clinicopathologic Features of IgG4-Related Kidney Disease
6. Mesangial Expansion by Morphometry at 5 y After Kidney Transplantation: Incidence, Risk Factors, and Association With Graft Loss
7. IgG4-Related Tubulointerstitial Kidney Disease
8. Mitochondrial Diseases in the Pediatric Kidney
9. Response to “Predictors of Kidney Recovery in Acute Interstitial Nephritis”
10. De novo pauci-immune glomerulonephritis in renal allografts
11. Clinicopathologic Features and Outcomes of Acute Leukemia Harboring Picalm::Mllt10 Fusion
12. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population
13. IgG4-Related Kidney Disease: Clinicopathologic Features, Differential Diagnosis, and Mimics
14. #4220 NOT JUST AIN? OTHER IMMUNE-CHECKPOINT INHIBITOR LESIONS: A SINGLE INSTITUTION'S EXPERIENCE OVER 12 YEARS
15. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones:biomarkers or mediators
16. IgG4-related kidney disease: Clinicopathologic features, differential diagnosis, and mimics
17. Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC
18. Abstract 14893: Structural Variant of the Designer Peptide MANP: Differential Actions With cGMP Activation in Cardiorenal Functions
19. Microalbuminuria and Left Ventricular Mass in Overweight and Obese Hypertensive Patients: Role of the Metabolic Syndrome
20. Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement
21. Microalbuminuria and Left Ventricular Mass in Overweight and Obese Hypertensive Patients: Role of the Metabolic Syndrome
22. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study
23. Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients
24. A gut-heart connection in cardiometabolic regulation
25. Monoclonal Gammopathy in ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis: Is There Causality? Case Series
26. A Case of ANCA-Associated Vasculitis with Glomerulonephritis Unmasked by Electron Microscopy
27. Monoclonal Gammopathy and Its Associations with Kidney Failure in Patients with ANCA-Associated Vasculitis
28. Kidney Dysfunction in Hematologic Malignancy Unveiling Anti-brush Border Antibody Disease
29. Immunohistochemical and Ultrastructural Features of Hepatocellular Cytoplasmic Globules in Venous Outflow Impairment
30. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study.
31. Mo1748 - Validation of Novel Methylated DNA Markers for the Detection of Esophageal Squamous Cell Carcinoma and Dysplasia: Multi-National Tissue Study
32. MANP: Structural Insights of a Novel GC-A Receptor and cGMP Activator with Cardiorenal Enhancing and Aldosterone Suppressing Actions in Vivo
33. Abstract 11603: Structural Insights Into C-terminus and N-terminus of a Designer cGMP Activating ANP-Based Antihypertensive Peptide: ZD100
34. Plasma Aldosterone, ANP, Hypertension and Stage A and B Heart Failure in the General Community
35. A novel particulate guanylyl cyclase receptor B/cGMP activator with selective vasodilating actions in experimental hypertension
36. ZD100 in a genetic model of essential hypertension and characterization of the role of the C-terminus of this novel designer peptide
37. Aldosterone levels, atrial natriuretic peptide and resistant hypertension in the general community
38. Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series
39. New Pharmacological Strategies to Increase cGMP
40. Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up
41. MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results
42. Acute Blood Pressure, Renal and cGMP Responses to the Novel Designer Natriuretic Peptide ZD100 in Spontaneously Hypertensive Rats
43. Plasma Aldosterone and Heart Failure in the General Community
44. 092 - MANP: Structural Insights of a Novel GC-A Receptor and cGMP Activator with Cardiorenal Enhancing and Aldosterone Suppressing Actions in Vivo
45. Circulating Aldosterone and Natriuretic Peptides in the General Community
46. PTH: Potential role in management of heart failure
47. Abstract 11026: Aldosterone Level in the General Community Predicts New Onset Cardiometabolic Disease
48. Aldosterone: Marker and Predictor of Cardiorenal and Metabolic Disease in the General Community
49. Circulating aldosterone in the general community: biomarker, mediator of cardiorenal and metabolic disease and inhibitor of the natriuretic peptide system
50. Glomerular Pathology of Vascular Endothelial Growth Factor Inhibition: 12-Year Single-Center Experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.